1st Quarter - Report · 2026

Filing UUID: 4818a50f-0b38-4752-87b4-cbf2a5f9fbcc
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-15 16:54:25
Income (reported): $40,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

ALB SOLUTIONS

â€‹Strategic advisory firm.

Contact: ADAM BUCKALEW
Phone: +1 202-579-2387
Address: zip:20002, city:Washington, state:DC, street:227 12th Street, NE

Client

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Pharmaceutical company.

State: CT
Country: US
Effective date: 2022-04-04

Issues lobbied + lobbyists

`PHA` — Pharmacy

Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.

Lobbyists: ADAM BUCKALEW (covered position: Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)); VERONICA JACKSON (covered position: Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS)

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.